ETON - Eton Pharmaceuticals Inc
IEX Last Trade
4.585
-0.015 -0.327%
Share volume: 35,284
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$4.60
-0.02
-0.33%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-16 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-03-14 | 2024-05-09 | |
| Total revenue | 7.358 M | 3.219 M | 8.498 M | 5.304 M | 11.997 M | 7.028 M | 7.313 M | 7.966 M | |
| Cost of revenue | 2.745 M | 1.201 M | 2.269 M | 1.958 M | 2.315 M | 2.625 M | 3.683 M | 2.959 M | |
| Gross profit | 4.613 M | 2.018 M | 6.229 M | 3.346 M | 9.682 M | 4.403 M | 3.630 M | 5.007 M | |
| -56.25% | 208.67% | -46.28% | 189.36% | -54.52% | -17.56% | 37.93% | |||
| Operating expenses | 5.953 M | 4.913 M | 5.167 M | 5.880 M | 5.799 M | 4.951 M | 5.623 M | 5.807 M | |
| Selling general and admin | 5.263 M | 4.169 M | 4.223 M | 5.345 M | 4.674 M | 4.336 M | 4.576 M | 5.156 M | |
| Research and development | 690.000 K | 744.000 K | 944.000 K | 535.000 K | 1.125 M | 615.000 K | 1.047 M | 651.000 K | |
| Total expenses | 8.698 M | 6.114 M | 7.436 M | 7.838 M | 8.114 M | 7.576 M | 9.306 M | 8.766 M | |
| -29.71% | 21.62% | 5.41% | 3.52% | -6.63% | 22.84% | -5.80% | |||
| Operating income | -1.340 M | -2.895 M | 1.062 M | -2.534 M | 3.883 M | -548.000 K | -1.993 M | -800.000 K | |
| Ebit | -1.340 M | -2.895 M | 1.062 M | -2.534 M | 3.883 M | -548.000 K | -1.993 M | -800.000 K | |
| Pretax income | -1.558 M | -3.045 M | 912.000 K | -2.660 M | 4.559 M | -579.000 K | -2.009 M | -811.000 K | |
| 95.44% | -129.95% | -391.67% | -271.39% | -112.70% | 246.98% | -59.63% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 247.000 K | 0.000 | |
| Net income basic | -1.558 M | -3.045 M | 912.000 K | -2.660 M | 4.559 M | -579.000 K | -2.256 M | -811.000 K | |
| -95.44% | 129.95% | -391.67% | 271.39% | -112.70% | -289.64% | 64.05% | |||
| Net income | -1.558 M | -3.045 M | 912.000 K | -2.660 M | 4.559 M | -579.000 K | -2.256 M | -811.000 K | |
| -95.44% | 129.95% | -391.67% | 271.39% | -112.70% | -289.64% | 64.05% |